
Continuing Medical Education Enhances Clinicians’ Knowledge of Homozygous Familial Hypercholesterolemia
Early treatment of homozygous familial hypercholesterolemia (HoFH) improves outcomes for children and reduces the risk of progressive atherosclerotic cardiovascular disease. Unfortunately, the disease often goes undetected until it is in the advanced stages. […]